Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients.

@article{Mercolini2014DriedBS,
  title={Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients.},
  author={Laura Mercolini and Roberto Mandrioli and Michele Protti and Andreas Conca and Lawrence James Albers and Maria Augusta Raggi},
  journal={Bioanalysis},
  year={2014},
  volume={6 11},
  pages={1487-95}
}
BACKGROUND A novel analytical approach, based on dried blood spot (DBS) testing, has been developed, validated and applied for the first time to the analysis of ziprasidone (ZPR) for the therapeutic drug monitoring (TDM) of schizophrenic patients. DBS represent a more feasible but reliable matrix, alternative to blood and plasma. METHODS The assays were carried out using an HPLC method with native fluorescence. Blood drops were applied to DBS cards and dried by microwaves, an internal… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-2 of 2 extracted citations

Similar Papers

Loading similar papers…